IOZK receives manufacturing authorization for the patient's own tumor vaccine

The IOZK received the GMP certificate and the official manufacturing authorization for the autologous tumor vaccine developed at the IOZK in combination with oncolytic viruses in accordance with the German Medicines Act for "advanced therapies."